Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China · Delayed Price · Currency is CNY 5.24
+0.06 (1.16%)
Sep 14, 2026, 3:00 PM CST
SHA:600713 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,947 | 3,050 | 4,563 | 2,373 | 2,328 | 2,095 |
Trading Asset Securities | 140.26 | 215.28 | - | - | - | - |
Cash & Short-Term Investments | 3,087 | 3,265 | 4,563 | 2,373 | 2,328 | 2,095 |
Cash Growth | 29.28% | -28.45% | 92.28% | 1.94% | 11.13% | 41.32% |
Accounts Receivable | 17,738 | 16,289 | 15,098 | 16,209 | 19,304 | 15,251 |
Other Receivables | 4,307 | 41.78 | 97.9 | 29.71 | 29.28 | 22.86 |
Receivables | 22,046 | 16,331 | 15,196 | 16,238 | 19,334 | 15,274 |
Inventory | 6,838 | 6,904 | 6,286 | 5,798 | 5,787 | 4,518 |
Other Current Assets | 1,278 | 1,912 | 1,763 | 1,603 | 1,813 | 1,571 |
Total Current Assets | 33,249 | 28,412 | 27,808 | 26,013 | 29,261 | 23,458 |
Property, Plant & Equipment | 2,030 | 2,004 | 1,885 | 1,507 | 1,519 | 1,492 |
Long-Term Investments | 254.6 | 269.24 | 283.47 | 237.64 | 206.45 | 254.18 |
Goodwill | 63.24 | 63.24 | 72.17 | 72.17 | 72.17 | 72.17 |
Other Intangible Assets | 217.54 | 209.49 | 215.68 | 218.98 | 245.28 | 268.11 |
Long-Term Deferred Tax Assets | 294.14 | 271.27 | 243.43 | 222.82 | 224.93 | 180.78 |
Long-Term Deferred Charges | 119.71 | 98.26 | 63.07 | 43.34 | 36.89 | 34.24 |
Other Long-Term Assets | 101.22 | 103.18 | 102.74 | 95.58 | 84.69 | 126.24 |
Total Assets | 36,329 | 31,430 | 30,674 | 28,410 | 31,651 | 25,886 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 10,817 | 11,098 | 10,176 | 9,694 | 10,131 | 8,064 |
Accrued Expenses | 291.51 | 335.81 | 369.49 | 363.63 | 438.32 | 379.33 |
Short-Term Debt | 4,855 | 4,759 | 3,760 | 4,574 | 8,414 | 7,036 |
Current Portion of Long-Term Debt | 91.53 | 195.14 | 900.98 | 2,223 | 1,409 | - |
Current Portion of Leases | - | 82.89 | 79.63 | 76.04 | 71.68 | 78.28 |
Current Income Taxes Payable | - | 174.13 | 87.6 | 91.48 | 102.89 | 136.01 |
Current Unearned Revenue | 258.93 | 333.99 | 278.67 | 103.57 | 219.12 | 74.78 |
Other Current Liabilities | 6,587 | 1,542 | 1,441 | 1,441 | 1,498 | 1,756 |
Total Current Liabilities | 22,901 | 18,520 | 17,094 | 18,566 | 22,284 | 17,525 |
Long-Term Debt | 4,641 | 4,146 | 5,339 | 2,118 | 2,222 | 2,628 |
Long-Term Leases | 178.43 | 192.07 | 116.18 | 119.02 | 103.23 | 124.4 |
Long-Term Unearned Revenue | 256.35 | 260.79 | 277.62 | 297.06 | 293.17 | 304.61 |
Long-Term Deferred Tax Liabilities | 48.79 | 58.04 | 59.05 | 55.41 | 54.24 | 69.9 |
Total Liabilities | 28,025 | 23,178 | 22,886 | 21,155 | 24,956 | 20,652 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,308 | 1,309 | 1,309 | 1,310 | 1,310 | 1,042 |
Additional Paid-In Capital | 2,460 | 2,454 | 2,466 | 2,460 | 2,429 | 1,380 |
Retained Earnings | 3,447 | 3,375 | 2,973 | 2,611 | 2,217 | 1,778 |
Treasury Stock | -39.19 | -51.33 | -20.9 | -35.9 | -38.58 | - |
Comprehensive Income & Other | 78.6 | 98.5 | 111.24 | 89.72 | 81.98 | 406.6 |
Total Common Equity | 7,255 | 7,185 | 6,838 | 6,435 | 6,000 | 4,606 |
Minority Interest | 1,049 | 1,068 | 949.87 | 819.73 | 695.03 | 627.46 |
Shareholders' Equity | 8,304 | 8,253 | 7,788 | 7,255 | 6,695 | 5,234 |
Total Liabilities & Equity | 36,329 | 31,430 | 30,674 | 28,410 | 31,651 | 25,886 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 9,766 | 9,375 | 10,196 | 9,110 | 12,219 | 9,867 |
Net Cash (Debt) | -6,679 | -6,110 | -5,633 | -6,737 | -9,891 | -7,772 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -4.53 | -4.17 | -4.32 | -5.19 | -7.89 | -7.46 |
Filing Date Shares Outstanding | 1,288 | 1,309 | 1,309 | 1,310 | 1,310 | 1,042 |
Total Common Shares Outstanding | 1,288 | 1,309 | 1,309 | 1,310 | 1,310 | 1,042 |
Working Capital | 10,349 | 9,891 | 10,714 | 7,447 | 6,978 | 5,933 |
Book Value Per Share | 5.63 | 5.49 | 5.22 | 4.91 | 4.58 | 4.42 |
Tangible Book Value | 6,974 | 6,912 | 6,550 | 6,144 | 5,682 | 4,266 |
Tangible Book Value Per Share | 5.41 | 5.28 | 5.00 | 4.69 | 4.34 | 4.10 |
Buildings | - | 1,452 | 1,463 | 1,133 | 1,166 | 1,046 |
Machinery | - | 962.26 | 928.24 | 890.32 | 839.29 | 762.13 |
Construction In Progress | - | 349.69 | 237.27 | 130.08 | 80.23 | 153.4 |